Published in Health and Medicine Week, March 29th, 2004
This study, conducted at the Endocrine Metabolic Center by J. Joseph Prendergast, MD, in Redwood City, California, appears in the January/February 2004 issue of Endocrine Practice.
The study shows that 26 of 27 patients showed improved nerve function using a quantitative testing device called the Neurometer CPT. Additionally, more than 59% of the patients in the study, all of whom exhibited abnormal nerve function prior to receiving treatment, obtained normal sensory...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.